MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

Search

AxoGen Inc

Cerrado

SectorSanidad

16.25 -4.19

Resumen

Variación precio

24h

Actual

Mínimo

15.73

Máximo

16.96

Métricas clave

By Trading Economics

Ingresos

2.3M

450K

Ventas

761K

49M

BPA

0.07

Margen de beneficios

0.911

Empleados

451

EBITDA

2.2M

4.2M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+52.58% upside

Dividendos

By Dow Jones

Próximas Ganancias

1 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

28M

820M

Apertura anterior

20.44

Cierre anterior

16.25

Noticias sobre sentimiento de mercado

By Acuity

67%

33%

354 / 386 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

AxoGen Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

4 abr 2025, 22:38 UTC

Acciones populares

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

4 abr 2025, 21:53 UTC

Charlas de Mercado

Maxeon's Supply Chain Move at Critical Time for Solar Panel Cos -- Market Talk

4 abr 2025, 21:44 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Trump Grants 75-Day Extension to Reach TikTok Deal -- 3rd Update

4 abr 2025, 21:00 UTC

Principales Noticias

Americans Were Souring on Trump's Economic Plans Even Before Tariff Bloodbath -- WSJ

4 abr 2025, 20:52 UTC

Charlas de Mercado

Peloton Likely to Escape Tariffs Unscathed -- Market Talk

4 abr 2025, 20:52 UTC

Principales Noticias

Trump Can Cut Teacher-Training Programs For Now, Supreme Court Says -- WSJ

4 abr 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

4 abr 2025, 20:48 UTC

Principales Noticias

The Score: Nike, Apple, Stellantis and More Stocks That Defined the Week -- WSJ

4 abr 2025, 20:45 UTC

Principales Noticias

Hiring Defied Expectations in March, With 228,000 New Jobs -- 6th Update

4 abr 2025, 20:32 UTC

Principales Noticias

Dow Tumbles 2,000 Points, Bonds Rally After China Retaliates Against Trump Tariffs -- WSJ

4 abr 2025, 20:21 UTC

Principales Noticias

China Hits Back at Trump With Sweeping Tariffs on All U.S. Goods -- Update

4 abr 2025, 20:00 UTC

Principales Noticias

Republicans March Ahead on Trump's Tax Cuts as Tariffs Kick In -- WSJ

4 abr 2025, 19:51 UTC

Charlas de Mercado

Dollar Recovers While Recession Fears Grip Wall Street -- Market Talk

4 abr 2025, 19:37 UTC

Principales Noticias

Trump's Team is Getting the Bond Rally It Wanted. But for the Wrong Reasons. -- WSJ

4 abr 2025, 19:32 UTC

Charlas de Mercado

Oil Selloff Continues as China Responds to U.S. Tariffs -- Market Talk

4 abr 2025, 19:28 UTC

Principales Noticias

U.S. Stocks Fall Further After China Retaliates Against Trump Tariffs -- Update

4 abr 2025, 19:15 UTC

Charlas de Mercado

Costco Gold, Membership Fees Could Help Cushion from Tariff Costs -- Market Talk

4 abr 2025, 19:12 UTC

Principales Noticias

Powell Warns of Higher Prices, Weaker Growth After Tariff Plan -- 3rd Update

4 abr 2025, 19:11 UTC

Charlas de Mercado

U.S. Natural Gas Falls as Global Selloff Continues -- Market Talk

4 abr 2025, 19:09 UTC

Charlas de Mercado

Mexican Stocks, Peso Tumble as Global Rout Continues -- Market Talk

4 abr 2025, 19:09 UTC

Principales Noticias

Trump Grants 75-Day Extension to Reach TikTok Deal -- Second Update

4 abr 2025, 19:00 UTC

Charlas de Mercado

Fed Has Limited Options to Counter Tariffs -- Market Talk

4 abr 2025, 18:53 UTC

Charlas de Mercado

Brace for Trump's Tariff Order to Remain in Place for Extended Period -- Market Talk

4 abr 2025, 18:51 UTC

Charlas de Mercado

Morgan Stanley Analysts Outline Paths to Recession -- Market Talk

4 abr 2025, 18:44 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

4 abr 2025, 18:44 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

4 abr 2025, 18:44 UTC

Charlas de Mercado

Tariffs Won't Achieve What Trump Wants, Morgan Stanley Says -- Market Talk

4 abr 2025, 18:43 UTC

Adquisiciones, fusiones, absorciones

Trump Extends Deadline for TikTok Ban Another 75 Days. ByteDance Says 'An Agreement Has Not Been Executed.' -- Barrons.com

4 abr 2025, 18:43 UTC

Adquisiciones, fusiones, absorciones

Trump Extends TikTok Ban Deadline A Second Time As Deal Chatter Swirls -- IBD

4 abr 2025, 18:39 UTC

Charlas de Mercado

Protectionism is Back, And Recession Could Follow, Morgan Stanley Says -- Market Talk

Comparación entre iguales

Cambio de precio

AxoGen Inc previsión

Precio Objetivo

By TipRanks

52.58% repunte

Estimación a 12 Meses

Media 26 USD  52.58%

Máximo 30 USD

Mínimo 24 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para AxoGen Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

6

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

N/A / 17.4Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

354 / 386 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de AxoGen Inc

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.